Neurocrine Biosciences, Inc.
Methods for the administration of certain VMAT2 inhibitors
Last updated:
Abstract:
Provided is a method of administering a vesicular monoamine transporter 2 (VMAT2) inhibitor to a subject in need thereof, wherein the subject has severe renal impairment.
Status:
Grant
Type:
Utility
Filling date:
10 Aug 2020
Issue date:
9 Mar 2021